Passa al contenuto
Merck

Xeno-immunogenicity of ice-free cryopreserved porcine leaflets.

The Journal of surgical research (2014-12-03)
Martina Seifert, Alexandra Bayrak, Meaghan Stolk, Naima Souidi, Maria Schneider, Ulrich A Stock, Kelvin G M Brockbank
ABSTRACT

Undesirable processes of inflammation, calcification, or immune-mediated reactions are limiting factors in long-term survival of heart valves in patients. In this study, we target the modulatory effects of ice-free cryopreservation (IFC) of xenogeneic heart valve leaflet matrices, without decellularization, on the adaptive human immune responses in vitro. We tested porcine leaflet matrices from fresh untreated, conventionally cryopreserved (CFC), and IFC pulmonary valves by culturing them with human blood mononuclear cells for 5 d in vitro. No other tissue treatment protocols to modify possible immune responses were used. Matrices alone or in addition with a low-dose second stimulus were analyzed for induction of proliferation and cytokine release by flow cytometry-based techniques. Evaluation of the α-Gal epitope expression was performed by immunohistochemistry with fluorochrome-labeled B4 isolectin. None of the tested leaflet treatment groups directly triggered the proliferation of immune cells. But when tested in combination with a second trigger by anti-CD3, IFC valves showed significantly reduced proliferation of T cells, especially effector memory T cells, in comparison with fresh or CFC tissue. Moreover, the cytokine levels for interferon-γ (IFNγ), tumor necrosis factor α, and interleukin-10 were reduced for the IFC-treated group being significantly different compared with the CFC group. However, no difference between treatment groups in the expression of the α-Gal antigen was observed. IFC of xenogeneic tissue might be an appropriate treatment method or processing step to prevent responses of the adaptive immune system.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Dimetil solfossido, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Dimetil solfossido, ACS reagent, ≥99.9%
Sigma-Aldrich
Dimetil solfossido, Molecular Biology
Sigma-Aldrich
Dimetil solfossido, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimetil solfossido, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Dimetil solfossido, ReagentPlus®, ≥99.5%
Sigma-Aldrich
2-Methylbutane, ReagentPlus®, ≥99%
Sigma-Aldrich
Saccarosio, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
Dimetil solfossido, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
Saccarosio, ≥99.5% (GC)
Sigma-Aldrich
Sodium azide, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Formamide, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
Saccarosio, ≥99.5% (GC), BioXtra
Sigma-Aldrich
Saccarosio, BioUltra, Molecular Biology, ≥99.5% (HPLC)
Sigma-Aldrich
L-glutammina, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
1,2-propandiolo, ≥99.5% (GC), FCC, FG
Supelco
Saccarosio, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Formamide, ≥99.5% (GC), BioReagent, Molecular Biology
Sigma-Aldrich
L-glutammina, ReagentPlus®, ≥99% (HPLC)
USP
Saccarosio, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Dimetil solfossido, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
Sodium azide, BioUltra, ≥99.5% (T)
Sigma-Aldrich
Formamide, BioUltra, Molecular Biology, ≥99.5% (T)
Sigma-Aldrich
Saccarosio, ≥99.5% (GC)
Sigma-Aldrich
Saccarosio, ≥99.5% (GC), BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Propylene Glycol, meets USP testing specifications
Millipore
Saccarosio, suitable for microbiology, ACS reagent, ≥99.0%
Sigma-Aldrich
Saccarosio, ACS reagent
SAFC
L-glutammina
Supelco
1,2-propandiolo, Pharmaceutical Secondary Standard; Certified Reference Material